NasdaqGS - Nasdaq Real Time Price USD

Milestone Pharmaceuticals Inc. (MIST)

1.3000
+0.0800
+(6.57%)
As of 2:05:15 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
1,000
5,000
15,000
Operating Expense
42,102
42,102
62,098
64,642
58,073
Operating Income
-42,102
-42,102
-61,098
-59,642
-43,073
Net Non Operating Interest Income Expense
583
583
1,413
1,254
220
Pretax Income
-41,519
-41,519
-59,685
-58,388
-42,853
Tax Provision
--
--
--
--
0
Net Income Common Stockholders
-41,519
-41,519
-59,685
-58,388
-42,853
Diluted NI Available to Com Stockholders
-41,519
-41,519
-59,685
-58,388
-42,853
Basic EPS
-0.67
--
-1.39
-1.38
-1.02
Diluted EPS
-0.67
--
-1.39
-1.38
-1.02
Basic Average Shares
62,210.7020
--
42,955.7790
42,450.3160
41,833.8610
Diluted Average Shares
62,210.7020
--
42,955.7790
42,450.3160
41,833.8610
Total Operating Income as Reported
-42,102
-42,102
-61,098
-59,642
-43,073
Total Expenses
42,102
42,102
62,098
64,642
58,073
Net Income from Continuing & Discontinued Operation
-41,519
-41,519
-59,685
-58,388
-42,853
Normalized Income
-41,519
-41,519
-59,685
-58,388
-42,853
Interest Income
4,164
4,164
3,967
1,254
220
Interest Expense
3,581
3,581
2,554
0
--
Net Interest Income
583
583
1,413
1,254
220
EBIT
-37,938
-37,938
-57,131
-58,388
-43,073
EBITDA
-37,833
-37,833
-57,039
-58,299
-42,980
Reconciled Depreciation
105
105
92
89
93
Net Income from Continuing Operation Net Minority Interest
-41,519
-41,519
-59,685
-58,388
-42,853
Normalized EBITDA
-37,833
-37,833
-57,039
-58,299
-42,980
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 5/9/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ABEO Abeona Therapeutics Inc.
6.20
+1.64%
 
CNTB Connect Biopharma Holdings Limited
0.7801
+2.38%
 
GRCE Grace Therapeutics, Inc.
2.9300
+4.64%
 
UNCY Unicycive Therapeutics, Inc.
0.6041
+1.38%
 
ATRA Atara Biotherapeutics, Inc.
6.57
-4.02%
 
PYPD PolyPid Ltd.
2.7900
+1.64%
 
SCPH scPharmaceuticals Inc.
3.4250
+6.37%
 
LPCN Lipocine Inc.
3.7400
-6.28%
 
ANNX Annexon, Inc.
2.0650
+2.74%
 
APLT Applied Therapeutics, Inc.
0.4812
-20.19%